All Stories

  1. Mental Health and Thinking Abilities: A New Way to Understand Their Connection

    Article • Journal of Psychopathology and Clinical Science, September 2025, American Psychological Association (APA)

    Orly Lipsitz

  2. Frameworks Used to Engage Postsecondary Students in Campus Mental Health Research: A Scoping Review

    Article • Health Expectations, March 2025, Wiley

    Orly Lipsitz

  3. The impact of comorbid cluster B traits and personality disorders on depression treatment outcome: a systematic review and meta-analysis

    Article • Nature Mental Health, October 2024, Springer Science + Business Media

    Orly Lipsitz

  4. Change in emotion appraisal and reappraisal in psychotherapy

    Article • January 2024, Elsevier

    Orly Lipsitz

  5. Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder

    Article • Journal of Psychopharmacology, November 2022, SAGE Publications

    Orly Lipsitz

  6. An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study

    Article • JMIR Mental Health, October 2022, JMIR Publications Inc.

    Orly Lipsitz

  7. Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence

    Article • Journal of Psychiatric Research, November 2021, Elsevier

    Orly Lipsitz

  8. The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine

    Article • Journal of Affective Disorders, November 2021, Elsevier

    Orly Lipsitz

  9. Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review

    Article • Journal of Affective Disorders, October 2021, Elsevier

    Orly Lipsitz

  10. Registered clinical studies investigating psychedelic drugs for psychiatric disorders

    Article • Journal of Psychiatric Research, July 2021, Elsevier

    Orly Lipsitz

  11. Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment

    Article • Journal of Affective Disorders, June 2021, Elsevier

    Orly Lipsitz

  12. The impact of overweight/obesity on monetary reward processing: A systematic review

    Article • Journal of Psychiatric Research, May 2021, Elsevier

    Orly Lipsitz

  13. Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence

    Article • Journal of Psychiatric Research, April 2021, Elsevier

    Orly Lipsitz

  14. A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions

    Article • Journal of Affective Disorders, March 2021, Elsevier

    Orly Lipsitz

  15. Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder

    Article • Journal of Affective Disorders, March 2021, Elsevier

    Orly Lipsitz

  16. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis

    Article • Journal of Psychiatric Research, February 2021, Elsevier

    Orly Lipsitz

  17. The influence of prescriber and patient gender on the prescription of benzodiazepines: results from the Florida Medicaid Dataset

    Article • CNS Spectrums, January 2021, Cambridge University Press

    Orly Lipsitz

  18. Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulation

    Article • CNS Spectrums, December 2020, Cambridge University Press

    Orly Lipsitz

  19. Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence

    Article • CNS Spectrums, December 2020, Cambridge University Press

    Orly Lipsitz

  20. Impact of COVID-19 pandemic on mental health in the general population: A systematic review

    Article • Journal of Affective Disorders, December 2020, Elsevier

    Orly Lipsitz

  21. Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence

    Article • Journal of Affective Disorders, November 2020, Elsevier

    Orly Lipsitz

  22. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis

    Article • Journal of Affective Disorders, November 2020, Elsevier

    Orly Lipsitz

  23. The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence

    Article • Journal of Psychopharmacology, October 2020, SAGE Publications

    Orly Lipsitz

  24. The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder

    Article • Bipolar Disorders, July 2020, Wiley

    Orly Lipsitz

  25. The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic Review

    Article • Journal of Affective Disorders, July 2020, Elsevier

    Orly Lipsitz

  26. Effect of body anthropometrics on brain structure of offspring of parents with bipolar disorder

    Article • Journal of Psychiatric Research, May 2020, Elsevier

    Orly Lipsitz